| Financial Year |
March 31 2023 |
| Monetary Funds |
1,508,209,249.98 |
| Held-for-trading Financial Assets |
348,914,716.35 |
| Notes Receivable |
17,024,000.00 |
| Accounts Receivable |
99,705,216.50 |
| Advances to Suppliers |
7,202,863.37 |
| Other Receivables |
24,107,229.76 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
246,474,937.97 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
161,098.53 |
| Other Current Assets |
34,316,226.27 |
| Total Current Assets |
2,297,946,509.91 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
29,502,264.86 |
| Investment Properties |
-- |
| Fixed Assetes |
673,092,864.86 |
| Under-construction Projects |
116,926,318.86 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
105,202,688.87 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,561,285.59 |
| Deferred Income Tax Assets |
35,572,706.20 |
| Other Non-Current Assets |
5,473,339.03 |
| Sub-Total of Non-Current Assets |
999,976,328.66 |
| Total Assets |
3,297,922,838.57 |
| Short-Term Loans |
278,879,322.68 |
| Trading Financial liabilities |
-- |
| Notes Payable |
153,890,171.24 |
| Accounts Payable |
180,410,272.45 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
34,913,293.75 |
| Taxes Payable |
9,645,422.57 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
110,535,594.11 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
108,185,572.30 |
| Other Current Liabilities |
127,465,254.61 |
| Sub-Total of Current Liabilities |
1,099,413,354.58 |
| Long-term Loans |
-- |
| Bonds Payable |
439,379,794.58 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
15,655,466.91 |
| Deferred Income Tax Liabilities |
1,712,859.29 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
498,805,289.34 |
| Total Liabilities |
1,598,218,643.92 |
| Paid-In Capital(Or Share Stock) |
408,769,511.00 |
| Capital Surplus |
494,729,031.58 |
| Surplus Reserve |
148,704,789.80 |
| LESS:Treasury Stock |
48,733,170.00 |
| Undistributed Profits |
596,409,155.13 |
| Minority Stockholder's Interest |
-119,567.27 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,699,823,761.92 |
| Owner's Equity（Stockholder's Equity） |
1,699,704,194.65 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,297,922,838.57 |
